Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

This study has been completed.
Information provided by (Responsible Party):
Janssen Research & Development, LLC Identifier:
First received: December 23, 2010
Last updated: November 24, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):